The Epidemiology of Variant Creutzfeldt-Jakob Disease

Current Topics in Microbiology and Immunology

Volumn 284, Issue , 2004, Pages 161-191

  Smith, P G ^a   Cousens, S N ^a   Huillard D'Aignaux, J N ^a   Ward, H J T ^b   Will, R G ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY; CODON; CREUTZFELDT JAKOB DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; EPIDEMIC; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IATROGENIC DISEASE; INCIDENCE; INCUBATION TIME; INFECTION CONTROL; INFECTION RISK; MATHEMATICAL MODEL; MORTALITY; OCCUPATIONAL EXPOSURE; PREDICTION; PRION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS STRAIN;

BOVINAE;

EID: 1642267100     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-08441-0_7     Document Type: Review

References (60)

1. Almond J, Pattison J. Human BSE. Nature 1997; 389:437-438
2. Alperovitch A, Will RG. Predicting the size of the vCJD epidemic in France. C.R.Acad. Sci III Biologies 2002; 325:33-36
3. Alperovitch A, Zerr I, Pocchiari M, Mitrova E, de Pedro Cuesta J, Hegyi I et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 1999; 353:1673-1674
4. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382:779-788
5. Andrews NJ, Farrington CP, Cousens SN, Smith PG, Ward HJT, Knight RS et al. Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000; 356:481-482
6. Andrews NJ, Farrington CP, Ward HJT, Cousens SN, Smith PG, Molesworth AM et al. Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 2003; 361:751-752
7. Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21:6358-6366
8. Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet 1995; 346:1155-1156
9. Britton TC, al-Sarraj S, Shaw C, Campbell T, Collinge J. Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet 1995; 346:1155
10. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-1081
11. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389:498-501
12. Bryant G, Monk PN. Final report of the investigation into the North Leicestershire cluster of variant Creutzfeldt-Jakob., http://www.leics-ha.org.uk/Publics/vcjd_rep. doc, 2001
13. Cooper JD, Bird SM. UK dietary exposure to BSE in beef mechanically recovered meat: by birth cohort and gender. J Cancer Epidemiol Prevent 2002; 7:59-70
14. Cousens S, Smith PG, Ward H, Everington D, Knight RSG, Zeidler M et al. Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000. Lancet 2001; 357:1002-1007
15. Cousens SN, Linsell L, Smith PG, Chandrakumar M, Wilesmith JW, Knight RSG et al. Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999; 353:18-21
16. Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic. Nature 1997a; 385:197-198
17. Cousens SN, Zeidler M, Esmonde TF, DeSilva R, Wilesmith JW, Smith PG et al. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. Br Med J 1997b; 315:389-395
18. d'Aignaux JH, Costagliola D, Maccario J, de Villemeur TB, Brandel JP, Deslys JP et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. American Academy of Neurology 1999; 53:1197-1201
19. Det Norske Veritas Consulting. Sources of BSE infectivity, http://www.foodstandards. gov.uk/multimedia/pdfs/sources_bse_infect.pdf, 2002
20. Ferguson NM, Donnelly CA, Ghani AC, Anderson RM. Predicting the size of the epidemic of new variant Creutzfeldt-Jakob disease. Br Food J 1999; 101:86-98.
21. Ferguson NM, Ghani AC, Donnelly AC, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 709:1-5
22. Gail MH, Brookmeyer R. Methods for projecting course of acquired immunodeficiency syndrome epidemic. J Natl Cancer Inst 1988; 80:900-911
23. Ghani AC, Ferguson NM, Donnelly CA, Hagenaars TJ, Anderson RM. Estimation of the number of people incubating variant CJD. Lancet 1998; 352:1353-1354
24. Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect Dis. 2003 3:4
25. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A. Sharply increased Creutzfeldt-Jakob disease mortality in Switzerland. Lancet 2002; 360:139-141
26. Gore SM. Commentary: Age related exposure of patients to the agent of BSE should not be downplayed. Br Med J 1997; 315:395-396
27. Gore SM. More than happenstance: Creutzfeldt-Jakob disease in farmers and young adults. Br Med J 1995; 311:1416-1418
28. Harris-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales 1980-84: a case-control study of potential risk factors. J Neurol, Neurosurg Psychiatr 1988; 51:1113-1119
29. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN, Thomas DK et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353:183-189
30. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature 1997; 389:448-450
31. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352:703-704
32. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Penney M et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br Med J 2002; 325:633-634
33. Horn G, Bobrow M, Bruce M, Goedert M, McLean A, Webster J. Review of the Origin of BSE: Report to UK Government. 2001 www.defra.gov.uk/animalh/bse/bseorigin.pdf
34. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356:999-1000
35. Huillard d'Aignaux J, Costagliola D, Maccario J, Billette de Villemeur T, Brandel JP, Deslys JP et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53:1197-1201
36. Huillard d'Aignaux JN, Cousens SN, Maccario J, Costagliola D, Alpers MP, Smith PG et al. The incubation period of kuru. Epidemiology 2002; 13:402-408
37. Huillard d'Aignaux JN, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001; 294:1729-1731
38. Hunter N, Foster JD, Chong A, McCutcheon S, Parnham DW, Eaton S et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83:2897-2905
39. Jackson GS, Beck JA, Navarrete C, Brown J, Sutton PM, Contreras M et al. HLA-DQ7 antigen and resistance to variant CJD. Nature 2001; 414:269-270
40. Kao RR, Gravenor MB, Baylis M, Bostock CJ, Chihota CM, Evans JC et al. The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep. Science 2002; 295:332-335
41. Laplanche JL, Lepage V, Peoc'h K, Delasnerie-Laupretre N, Charron D. HLA in French patients with variant Creutzfeldt-Jakob disease. Lancet 2003; 361:531-532
42. Lee HS, Brown P, Cervenakova L, Garruto RM, Alpers MP, Gajdusek DC et al. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 2001; 183:192-196
43. Liberski PP, Gajdusek DC. Kuru: forty years later, a historical note. Brain Pathol 1997; 7:555-560
44. Lloyd SE, Onwuazor ON, Beck JA, Mallinson G, Farrall M, Targonski P et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 2001; 98:6279-6283
45. Lowe J. Evidence of a CJD epidemic may still be missed. Br Med J 2000; 320:1011
46. McLean AR, Bostock CJ. Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. Philos Trans R Soc Lond B Biol Sci 2000; 355:1043-1050
47. Minor PD, Will RG, Salisbury D. Vaccines and variant CJD. Vaccine 2000; 19:409-410
48. National CJD Surveillance Unit. Creutzfeldt-Jakob disease surveillance in the UK, http://www.cjd.ed.ac.uk/rep2001.html, 2002
49. Parry HB. Scrapie disease in sheep: historical, clinical, epidemiological and practical aspects of the natural disease. London, Academic Press, 1983
50. Pepys MB, Bybee A, Booth DR, Bishop MT, Will RG, Little A-M et al. MHC typing in variant Creutzfeldt-Jakob disease. Lancet 2003; 361:487-489
51. Prusiner SB, Gajdusek DC, Alpers MP. Kuru with Incubation Periods Exceeding Two Decades. Am Neurolog 1982; 12:1-9
52. Sartwell PE. The distribution of incubation periods of infectious disease. Am J Hyg 1950; 51:310-318
53. Valleron A-J, Boelle P-Y, Will R, Cesbron J-Y. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294:1726-1728
54. van Duijn CM, Delasnerie-Laupetre N, Masullo C, Zerr I, de Silva R, Wientjens DPWM et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. Lancet 1998; 351:1081-1085
55. Verity CM, Nicoll A, Will RG, Devereux G, Stellitano L. Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study. Lancet 2000; 356:1224-1227
56. Wientjens DPWM, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG et al. Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996; 46:1287-1291
57. Wilesmith JW, Ryan JBM, Hueston WD, Hoinville LJ. Bovine spongiform encephalopathy: epidemiological features 1985-1990. Veterinary Record 1992; 130:90-94
58. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-925
59. Will RG, Matthews WB, Smith PG, Hudson C. A retrospective study of Creutzfeldt-Jakob Disease in England and Wales 1970-1979 II: epidemiology. J Neurol, Neurosurg Psychiatr 1986; 49:749-755
60. Working Party on Bovine Spongiform Encephalopathy. Report of the Working Party on Bovine Spongiform Encephalopathy (Southwood Report). London, UK, Dept of Health and Ministry of Agriculture, Food and Fisheries, 1989